AAIPharma Services Announces Compendial Testing Facility Expansion
WILMINGTON, N.C., March 30, 2011 /PRNewswire/ -- AAIPharma Services Corp., a leading provider of pharmaceutical product development and manufacturing services, has relocated its compendial raw materials testing group to a new purpose-built laboratory space located within the company's Wilmington, N.C., headquarters facility. The move follows a series of recent reinvestments into the company's core analytical testing business.
The new laboratory will tie together the compendial raw material testing lab and its supporting business group under one roof. The new location will increase turnaround times for high-quality raw materials testing; a standard 10-day turnaround will be offered for most compendial raw materials.
Features of the new GMP laboratory space include state-of-the-art engineering controls, updated IT infrastructure utilizing Waters Empower-2™ Chromatography Network data acquisition software, updated gas generation systems to support the dedicated Agilent 6890 gas chromatographs, HPLC systems for improved sample through-put and completely updated support systems down to the new Milli-Q water systems and Lancer Laboratory Glassware Washer. In addition, the move integrates AAIPharma Services' Physical Chemistry and Raw Materials Laboratories to provide full service Compendial Testing and API characterization in-house.
In addition to allowing the Compendial Testing Group to provide better customer service, group manager Ryan Taro states, "The new lab space also improves integration with other AAIPharma Services lines of business." For example, it supports solid dose and sterile manufacturing and packaging operations through enhanced communications and processing to prevent delays in having raw materials released for those facilities. It also dovetails with the newly created Quality Assurance Lab Service team responsible for overseeing data review.
According to Taro, "This investment is one more sign of the commitment AAIPharma Services has to its customers in providing top-notch, cGMP testing services to support pharmaceutical and biotech industries." Future improvements will include implementation of an online quotation and sample submission system that will facilitate how clients request quotes and submit samples for testing.
The recent lab move is a physical relocation of current lab operations, not a "laboratory site change" associated with the transfer of lab operations from one company to another. AAIPharma Services welcomes clients to audit or tour the new facility, which is conveniently located just two miles from Wilmington International Airport.
About AAIPharma Services Corp.
AAIPharma Services Corp. is a leading provider of services that encompass the entire pharmaceutical drug development process from discovery through commercialization. The company, which has the benefit of more than 30 years of experience, specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. It is headquartered in Wilmington, North Carolina. For more information, visit our website at www.aaipharma.com.
SOURCE AAIPharma Services Corp.
More by this Source
AAIPharma Appoints Senior Director of Parenteral Operations
Jan 24, 2013, 08:00 ET
AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
Jan 22, 2013, 08:00 ET
AAIPharma Expands Capacity of Parenteral Manufacturing Facility
Dec 20, 2012, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.